Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth despite labour code cost

Shares of Aurobindo Pharma Ltd ended at ₹1,201.25, up by ₹10.10, or 0.85%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *